Brand Name Drugs. If the subscriber chooses a brand name drug when a bioequivalent generic drug is available, the subscriber is required to pay the standard copayment plus the difference between the cost of the brand name drug and the generic. Amounts above the copay that an individual elects to pay for a brand name instead of a generic drug will not be credited toward the out-of-pocket maximum.
Appears in 129 contracts
Samples: Agreement, Agreement, Master Agreement
Brand Name Drugs. If the subscriber chooses a brand name drug when a bioequivalent generic drug is available, the subscriber is required to pay the standard copayment plus the difference between the cost of the brand name drug and the generic. Amounts above the copay that an individual elects to pay for a brand name instead of a generic drug will not be credited toward the out-out- of-pocket maximum.
Appears in 26 contracts
Brand Name Drugs. If the subscriber chooses a brand name drug when a bioequivalent generic drug is available, the subscriber is required to pay the standard copayment plus the difference between the cost of the brand name drug and the generic. Amounts above the copay that an individual elects to pay for a brand name instead of a generic drug will not be credited toward the out-of-of- pocket maximum.
Appears in 5 contracts
Samples: Master Agreement, Master Agreement, www.minnstate.edu
Brand Name Drugs. If the subscriber chooses a brand name drug when a bioequivalent generic drug is available, the subscriber is required to pay the standard copayment plus the difference between the cost of the brand name drug and the generic. Amounts above the copay that an individual elects to pay topay for a brand name instead of a generic drug will not be credited toward the out-out- of-pocket maximum.
Appears in 2 contracts
Brand Name Drugs. If the subscriber chooses a brand name drug when a bioequivalent generic drug is available, the subscriber is required to pay the standard copayment plus the difference between the cost of the brand name drug and the generic. Amounts above the copay that an individual elects to pay for payfor a brand name instead of a generic drug will not be credited toward the out-of-pocket maximum.
Appears in 1 contract
Samples: Labor Agreement
Brand Name Drugs. If the subscriber chooses a brand name drug when a 6 bioequivalent generic drug is available, the subscriber is required to pay the 7 standard copayment plus the difference between the cost of the brand name drug 8 and the generic. Amounts above the copay that an individual elects to pay for a 9 brand name instead of a generic drug will not be credited toward the out-of-pocket 10 maximum.
Appears in 1 contract
Samples: Labor Agreement
Brand Name Drugs. If the subscriber chooses a brand name drug when a 9 bioequivalent generic drug is available, the subscriber is required to pay the 10 standard copayment plus the difference between the cost of the brand name drug 11 and the generic. Amounts above the copay that an individual elects to pay for a 12 brand name instead of a generic drug will not be credited toward the out-of-pocket 13 maximum.
Appears in 1 contract
Samples: Labor Agreement
Brand Name Drugs. If the subscriber chooses a brand name drug when a bioequivalent generic drug is available, the subscriber is required to pay the standard copayment plus the difference between the cost of the brand name drug and the generic. Amounts above the copay that an individual elects to pay for a brand name instead of a generic drug will not be credited toward the out-of-pocket out‐of‐pocket maximum.
Appears in 1 contract
Samples: Agreement
Brand Name Drugs. If the subscriber chooses a brand name drug when a bioequivalent generic drug is available, the subscriber is required to pay the standard copayment plus the difference between the cost of the brand name drug and the generic. Amounts above the copay pay that an individual elects to pay for a brand name instead of a generic drug will not be credited toward the out-of-pocket maximum.
Appears in 1 contract
Samples: www.leg.mn.gov
Brand Name Drugs. If the subscriber chooses a brand name drug when a bioequivalent 31 generic drug is available, the subscriber is required to pay the standard copayment plus the 1 difference between the cost of the brand name drug and the generic. Amounts above the 2 copay that an individual elects to pay for a brand name instead of a generic drug will not be 3 credited toward the out-of-pocket maximum.
Appears in 1 contract
Samples: Agreement